BioSpace News Archive

Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, has selected BardyDx to participate in the organization’s 2019 Showcase program, featuring the most promising medical technologies from around the globe

June is designated Dysphagia Awareness Month by the National Foundation of Swallowing Disorders.

Collaboration will Leverage Nurix’s Proprietary Drug Discovery Platform to Identify Novel Agents that Induce Degradation of Specified Drug Targets

New global guidelines have been announced to tackle the lack of advice in the best use of denture adhesives with complete edentulous patients.

CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology, today highlighted that arimoclomol licensee Orphazyme A/S (ORPH.CO) has updated the anticipated timing for submission of its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval for arimoclomol in Niemann-Pick disease Type C (NPC)

C4 Recovery Foundation, in collaboration with The Center for Internet and Technology Addiction and GLOO, has gathered top experts in the field of technology and addiction to offer an educational event - Issues and Innovations: Digital Technology and The Future of Behavioral Health.

RAD Women (#RADxx), a networking and mentorship group for women in radiology, informatics, and IT management of radiology systems has today announced a new speakers bureau

The Leukemia & Lymphoma Society’s Students of the Year fundraising campaign fuels multigenerational impact

The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week.

Phoenix, LLC, a Madison, WI nuclear technology company, and SHINE Medical Technologies, a Janesville, WI medical isotope production company, announced completion of a 132-hour test of the high-flux Phoenix neutron generator that will drive SHINE’s medical isotope production system.